A Research Study to Assess the Safety, Pharmacokinetics and Pharmacodynamics of DUR-928 in Patients With Alcoholic Hepatitis
Public ClinicalTrials.gov record NCT03432260. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
An Open- Label, Dose Escalation Study to Assess the Safety, Pharmacokinetics and Pharmacodynamic Signals of DUR-928 in Patients With Alcoholic Hepatitis
Study identification
- NCT ID
- NCT03432260
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Durect
- Industry
- Enrollment
- 19 participants
Conditions and interventions
Conditions
Interventions
- DUR-928 30 mg Drug
- DUR-928 90 mg Drug
- DUR-928 150 mg Drug
Drug
Eligibility (public fields only)
- Age range
- 21 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 17, 2018
- Primary completion
- Sep 8, 2019
- Completion
- Sep 8, 2019
- Last update posted
- Sep 23, 2024
2018 – 2019
United States locations
- U.S. sites
- 7
- U.S. states
- 7
- U.S. cities
- 7
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| DURECT Study Site 0001 | San Diego | California | 92118 | — |
| DURECT Study Site 007 | Miami | Florida | 33136 | — |
| DURECT Study Site 0004 | Atlanta | Georgia | 30309 | — |
| DURECT Study Site 0002 | Chicago | Illinois | 60611 | — |
| DURECT Study Site 008 | Indianapolis | Indiana | 46202 | — |
| DURECT Study Site 0005 | Louisville | Kentucky | 40202 | — |
| DURECT Study Site 006 | San Antonio | Texas | 78215 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03432260, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 23, 2024 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03432260 live on ClinicalTrials.gov.